Renovaro Inc. Files 10-Q for Q3 2025
Ticker: LNAI · Form: 10-Q · Filed: May 15, 2025 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Renovaro Inc. (LNAI) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: RENB
TL;DR
Renovaro Inc. (RENB) filed its Q3 2025 10-Q. Check financials.
AI Summary
Renovaro Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Enochian Biosciences Inc. and Renovaro Biosciences Inc., is in the pharmaceutical preparations industry. Its principal executive offices are located at Century City Medical Plaza in Los Angeles, California.
Why It Matters
This filing provides investors with an update on Renovaro Inc.'s financial performance and operational status for the third quarter of fiscal year 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains financial and operational details that could impact the company's stock price, but it does not represent a major event like an acquisition or bankruptcy.
Key Players & Entities
- Renovaro Inc. (company) — Filer of the 10-Q
- Enochian Biosciences Inc. (company) — Former name of Renovaro Inc.
- Renovaro Biosciences Inc. (company) — Former name of Renovaro Inc.
- 20250331 (date) — Period of report for the 10-Q
- 20250515 (date) — Filing date of the 10-Q
- Los Angeles, CA (location) — Business and mail address city and state
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, meaning the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20250515.
What were Renovaro Inc.'s former names?
Renovaro Inc. was formerly known as Enochian Biosciences Inc. (name change 20230804) and Renovaro Biosciences Inc. (name changes 20230807 and 20230802).
What is Renovaro Inc.'s Standard Industrial Classification (SIC) code?
Renovaro Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Renovaro Inc. headquartered?
Renovaro Inc.'s business and mail address is Century City Medical Plaza, 2080 Century City East, Suite 906, Los Angeles, CA 90067.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding RENOVARO INC. (LNAI).